Similar Articles
51 Comment on “Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression”
52 Discussion on gemcitabine combined with targeted drugs in the treatment of pancreatic cancer
53 Irreversible electroporation for the management of pancreatic cancer: Current data and future directions
54 Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options
55 Low preoperative skeletal muscle index increases the risk of mortality among resectable pancreatic cancer patients: A retrospective study
56 Sarcopenia in pancreatic cancer: Effect on patient outcomes
57 Liquid biopsy leads to a paradigm shift in the treatment of pancreatic cancer
58 Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis
59 Previous hepatitis B viral infection–an underestimated cause of pancreatic cancer
60 International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: A joinpoint regression analysis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA